Publication: An N-nitrosating metalloenzyme constructs the pharmacophore of streptozotocin
Open/View Files
Date
2019-02
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Springer Science and Business Media LLC
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Ng, T.L., Rohac, R., Mitchell, A.J. et al. An N-nitrosating metalloenzyme constructs the pharmacophore of streptozotocin. Nature 566, 94–99 (2019). https://doi.org/10.1038/s41586-019-0894-z
Research Data
Abstract
N-nitroso-containing small molecules, such as the bacterial natural product streptozotocin, are prominent carcinogens as well as important cancer chemotherapeutics. Despite this functional group’s significant impact on human health, dedicated enzymes involved in N-nitroso assembly have not been identified. Here, we describe a metalloenzyme from streptozotocin biosynthesis (SznF) that catalyzes an unprecedented oxidative rearrangement of the guanidine group of Nw-methyl-L-arginine to generate an N-nitrosourea product. Structural characterization and mutagenesis of SznF uncovered two separate active sites that promote distinct steps in this transformation using different iron-containing metallocofactors. The discovery of this biosynthetic reaction, which has little precedent in enzymology or organic synthesis, expands the catalytic capabilities of non-heme iron-dependent enzymes to include N–N bond formation. We find biosynthetic gene clusters encoding SznF homologs are widely distributed among bacteria, including environmental organisms, plant symbionts, and human pathogens, suggesting an unexpectedly diverse and uncharacterized microbial reservoir of bioactive N-nitroso metabolites.
Description
Other Available Sources
Keywords
Multidisciplinary
Terms of Use
Metadata Only